# How GLP-1 users’ grocery choices may reshape family meals

By MarketScale Newsroom · Published 2026-11-17 · Food & Beverage on MarketScale
Canonical: https://www.marketscale.com/industries/food-beverage/why-glp-1-drugs-are-changing-food-for-people-who-never-take-them

> Most GLP-1 users are the main household grocery shopper. That can push food makers toward more protein and fiber per serving and smaller portions.

## Key points

- Only 9% of consumers managing their weight use medication, according to Innova data, but 94% of GLP-1 users in EY-Parthenon's survey are primary grocery shoppers, so their choices could reach people who never take the drug.
- Reported cutbacks show how many shoppers changed, and spend gaps are the closer guide to volume: 63% of US users say they eat fewer sweets, while UK users spend 10% less on desserts than non-users.
- Smaller portions raise the per-serving bar: a protein or fiber claim that held at the old pack size needs a denser formula to survive a smaller one.

Ninety-four percent of the GLP-1 users EY-Parthenon surveyed this year are the main grocery shopper in their home, so the changes in what they buy often extend to household meal planning, cooking habits and grocery purchases.

In a guest post on Food Industry Executive, Yannick Verry, brand director of Fi Events, argues that GLP-1 drugs are reshaping eating habits beyond the people taking them. He cites Innova data showing that most consumers trying to manage their weight do it through exercise (64%) or by eating fewer calories (46%). Only 9% use medication.

For product developers and portfolio leads at packaged food companies, the question that follows could be this: what does a whole household eat once the person buying for it starts eating smaller, denser meals?

## One prescription, a whole household's groceries

The EY-Parthenon survey ran from March to May 2026 and covered 14,883 general-population respondents plus 3,602 current or former GLP-1 users, with results compared against its 2024 and 2025 editions. Weight management is now the main reason US GLP-1 users give for taking the drug. At 54%, that share has passed half for the first time, and it now outranks use for diabetes and other health conditions. The report says the findings suggest GLP-1 adoption is increasingly affecting what consumers eat and drink and how they shop.

The Food Institute's write-up of the report carries the household number: 42% of users say they have adjusted their families' meals. That is the rate at which a personal prescription becomes a household menu change, and it is the figure that turns a pharmacy trend into a food-industry one. For food makers, that suggests a user's buying choices could shape what people who never take the drug end up eating.

Block Field

Those figures look inconsistent until you compare like with like. Food Business News, where Russell Redman reported the EY numbers, describes adults who have ever tried a GLP-1; Bain & Company's forecast, reported by Jessica Newman in The Times, counts people currently taking one. The gap is consistent with short treatment spells. The Food Institute reports that people generally stay on the drugs for six to 12 months, and 52% of past users say they're likely to restart.

For demand planners, that suggests more households may have lived with GLP-1 eating habits at some point than the number on the drug in any given month would indicate. Households that went through a spell of smaller meals could still be part of the market these products serve, even if no one in them is currently on the drug.

## What leaves the cart, and how far

EY-Parthenon's category data shows where users say their eating and drinking has moved. Users are eating fewer sweets and salty snacks and more fresh produce and protein.

Block Field

Bain's UK work measures something different: spending. GLP-1 users there spend 10% less on desserts and sweet treats than non-users, and 9% less on salty snacks, bread and other baked goods. They spend more on meal replacements, vitamins and supplements, fish, fruit and vegetables. At restaurants, users spend 8% less on burgers and puddings and 2% more on salads.

Put the two side by side and a planning lesson appears. A 63% figure for "fewer sweets" counts how many users changed; it says nothing about how much each one cut. Bain's spend gap on desserts is 10%. Different countries and methods mean one figure cannot be converted into the other, but together they suggest category demand among users thins rather than disappears. Reported-behavior percentages measure reach. The spend gap is the closer guide to volume.

Beverage portfolios get a similar split. Half of US users (51%) drink fewer soft drinks while 44% drink more functional beverages, and 45% have cut back on alcohol, with 40% saying they've stopped. For a beverage company with lines on both sides of that divide, the movement could be a shift between shelves as much as a loss.

## Portion, protein and the per-serving math

Verry's argument is that smaller portions and higher expectations of feeling full raise the bar for every bite. Protein, fiber and micronutrient density per serving matter more, and single-serve packs and mini meals follow. He writes that protein is back in the headlines for helping consumers hold on to their muscle mass and bridge the hunger gaps that big meals used to fill.

The consultancies reach the same conclusion. EY-Parthenon's report, as summarized by the Food Institute, advises established brands to reformulate by adding fiber and protein and removing sugar and calories. It also advises them to change snack packaging and portion sizes so that consumers see those snacks differently and treat them as more permissible, to use GLP-1 friendly labels with shorter ingredient lists, and to reposition products as healthier, premium and more nutritious. The report lists further options: new launches targeting the GLP-1 market, expansion into wellness categories, more spending on research and development, purchases of high-growth brands, and divestment of legacy lines that don't match the new trend. According to The Times, Sarah Hershey, a Bain partner who carried out the research with her team, said packaged goods companies should build out their offerings to meet demand for smaller portions and for foods rich in fiber and protein. She added that grocers should look at ways to expand the health and wellness aisles in their shops.

Here is where the work gets concrete. Shrink a pack and the protein and fiber in it shrink too, unless the formula gets denser. A claim that held at the old serving size could fall short at the new one. That fits Verry's point that protein, fiber and micronutrient density per serving matter more.

Block Field

Verry's labeling advice is specific: lead with attributes such as high protein, fiber and portion size rather than naming GLP-1s. As reported, EY-Parthenon's recommendation to adopt "GLP-1 friendly" labels means shorter ingredient lists, which suggests both point at what is in the product rather than the drug. There could be a commercial logic too. An attribute claim could also reach the shoppers in the Innova data who manage weight through exercise (64%) or by cutting calories (46%), not only the 9% using medication.

## Six personas at one dinner table

One objection to the household reading comes from EY-Parthenon's own report. It sorts GLP-1 consumers into six distinct personas and finds that uptake and changes in behavior differ widely from one user to the next. The report says this is further reason brands should not take a one-size-fits-all approach. The users also skew in particular directions: the Food Institute reports 64% are younger than 45, 64% are female and 27% earn more than $150,000 a year. People generally use the drugs for six to 12 months, so a household that changed its meals could drift back once the user stops. The 52% restart figure cuts the other way, but nothing in the data yet shows how long a family's new habits outlast the prescription.

Bain's restaurant guidance points at the same tension from the dining room. Hershey advised operators to meet users' needs through menu innovation without alienating the broader customer base, and to rethink social eating because users still want to eat with friends and family. A shared table is a strong argument for products everyone in the house will eat, such as smaller portions and denser nutrition, over a niche SKU aimed only at the person on the drug.

Who should act first depends on the portfolio. For brands with most of their volume in sweet snacks, salty snacks or baked goods, the per-serving rework is the near-term job. For brands already selling fresh, protein-forward or functional products, the opening is in pack size and in on-pack claims. The figure to watch is EY-Parthenon's household number. If a fourth annual survey follows the same schedule and the 42% share of users changing family meals rises, the spillover is widening. If it stays flat, the shift may stay closer to the user's own plate than the 94% shopper figure implies.

## Sources

- [The GLP-1 Ripple Effect: How Weight Loss Medications Are Reshaping Food and Drink for Absolutely Everyone](https://foodindustryexecutive.com/2026/11/the-glp-1-ripple-effect-how-weight-loss-medications-are-reshaping-food-and-drink-for-absolutely-everyone/) (Food Industry Executive)
- [EY-Parthenon GLP-1 Consumer Impact Report](https://www.prnewswire.com/news-releases/ey-parthenon-glp-1-consumer-impact-report-majority-of-glp-1-users-seek-weight-management-reshaping-shopping-carts-302916849.html) (PR Newswire)
- [Snack consumption squeezed by surging GLP-1 adoption](https://www.foodbusinessnews.net/articles/31233-snack-consumption-squeezed-by-surging-glp-1-adoption) (Food Business News)
- [GLP-1 Growth Serves Up New Food Trends](https://foodinstitute.com/consumerinsights/glp-1-growth-serves-new-food-trends/)
- [Weight-loss drug users to double as new appetites alter ...](https://www.thetimes.com/business/companies-markets/article/weight-loss-drug-users-to-double-as-new-appetites-alter-shopping-p5w26xlf9)

Tags: GLP-1, EY-Parthenon, Bain & Company, Fi Events, packaged food, product development, reformulation, portion size, protein and fiber, category management, demand planning, grocery retail, consumer insights

---
Source: MarketScale, https://www.marketscale.com/industries/food-beverage/why-glp-1-drugs-are-changing-food-for-people-who-never-take-them. Published for AI indexing and citation; cite the canonical URL. Site guide for agents: https://www.marketscale.com/llms.txt
